{"id":141513,"date":"2023-02-14T06:21:57","date_gmt":"2023-02-14T11:21:57","guid":{"rendered":"https:\/\/44.250.171.167\/?p=141513"},"modified":"2023-02-14T06:22:00","modified_gmt":"2023-02-14T11:22:00","slug":"ipca-laboratories-limited-q3-fy23-revenue-increased-to-%e2%82%b91546-crore","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/ipca-laboratories-limited-q3-fy23-revenue-increased-to-%e2%82%b91546-crore\/","title":{"rendered":"Ipca Laboratories Limited Q3 FY23; Revenue Increased To \u20b91,546 Crore"},"content":{"rendered":"

Ipca Laboratories Limited<\/a> (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of \u20b91,546 Crore up from \u20b91,430.47 Crore year on year, a growth of 8%. The Consolidated Net Profit of \u20b9107.84 Crore, down 45% from \u20b9196.96 Crore in the same quarter of the previous year. The Earnings per Share is \u20b94.25 for this quarter.<\/p>\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of \u20b91,546 Crore up from \u20b91,430.47 Crore year on year, a growth of 8%. The Consolidated Net Profit of \u20b9107.84 Crore, down 45% from \u20b9196.96 Crore in the same quarter of the previous year. The Earnings per Share is \u20b94.25 for this quarter.<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[1115],"class_list":["post-141513","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":142932,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-ipca-laboratories-limited-for-q3-fy23\/","url_meta":{"origin":141513,"position":0},"title":"Earnings Summary Of IPCA Laboratories Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 27, 2023","format":false,"excerpt":"Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription drugs, APIs (Active Pharmaceutical Ingredients), and intermediates. The company was founded in 1949 and is headquartered in Mumbai, India. It has a global presence with operations in over\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":147519,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-ipca-laboratories-industries-limited-for-q4-fy23\/","url_meta":{"origin":141513,"position":1},"title":"Earnings Summary Of Ipca Laboratories Industries Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 30, 2023","format":false,"excerpt":"Ipca Laboratories Limited is a leading pharmaceutical company headquartered in Mumbai, India. With over 75 years of experience, the company specializes in the development, manufacture, and marketing of a wide range of pharmaceutical products. Ipca Labs has a strong presence both in the domestic market of India and in several\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":181114,"url":"https:\/\/alphastreet.com\/india\/ipca-labs-posts-6-6-revenue-growth-in-q3-profit-boosted-by-one-time-asset-disposal\/","url_meta":{"origin":141513,"position":2},"title":"IPCA Labs Posts 6.6% Revenue Growth in Q3; Profit Boosted by One-Time Asset Disposal","author":"Staff Correspondent","date":"February 16, 2026","format":false,"excerpt":"IPCA Laboratories Limited (NSE: IPCALAB) on Friday reported a 31.5% year-on-year increase in consolidated net profit for the third quarter ended December 31, 2025. The result was bolstered by steady growth in its core pharmaceutical operations and a one-time gain from the disposal of assets. The Mumbai-based pharmaceutical major\u2019s board\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":172961,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-q2-fy26-earnings-results\/","url_meta":{"origin":141513,"position":3},"title":"Ipca Laboratories Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"December 9, 2025","format":false,"excerpt":"Ipca Laboratories Ltd, engaged in manufacturing and marketing of pharmaceuticals, reported robust financial performance for Q2FY26 with revenue growth across domestic formulations, exports, and APIs. Financial Highlights: Revenues increased 8.54% year-on-year to \u20b92,556 crore from \u20b92,355 crore, with domestic formulations up 8% to \u20b91,019 crore and exports up 7% to\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/IPCA.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152278,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q1fy24-13-rise-in-profits\/","url_meta":{"origin":141513,"position":4},"title":"Ipca Laboratories Ltd Q1FY24; 13% rise in Profits","author":"Hardik Bhandare","date":"August 10, 2023","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68) Financial Results: Ipca Laboratories Ltd reported Revenues for Q1FY24 of \u20b91,588.00 Crores up from \u20b91,586.00 Crore year on year, a rise of 0.13%. Total Expenses for Q1FY24 of \u20b91,380.00 Crores down from\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167062,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q3fy25-25-rise-in-profits\/","url_meta":{"origin":141513,"position":5},"title":"Ipca Laboratories Ltd Q3FY25; 25% rise in Profits","author":"Chirag Gupta","date":"February 25, 2025","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25 of \u20b92,245.00 Crores up from \u20b92,053.00 Crore year on year, a rise of 9.35%. Total Expenses for Q3FY25 of \u20b91,897.00 Crores up from \u20b91,855.00 Crores year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=141513"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/141513\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=141513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=141513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=141513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}